PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the field of biopharmaceuticals, providing promising enhancements across various healthcare and industrial purposes. With its structural similarity to By natural means derived human serum albumin, OsrHSA supplies a safer, far more reputable substitute for therapeutic use,